Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ebiogen is a South Korean biotechnology company specializing in multi-omics data analysis and bioinformatics services. The company provides comprehensive solutions for genomic, transcriptomic, and epigenomic research, supporting drug discovery and biomarker identification for pharmaceutical and academic clients. Beyond its service offerings, Ebiogen leverages its proprietary analysis platforms to identify novel therapeutic targets and develop its own internal pipeline of candidates. The company is recognized for its expertise in high-throughput sequencing data interpretation and its role as a key contract research organization (CRO) in the East Asian biotech ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ebiogen.